This HTML5 document contains 113 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n6http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43292405
rdf:type
wikibase:Item
schema:description
bilimsel makale articolo scientifico wissenschaftlicher Artikel videnskabelig artikel tudományos cikk 2009年學術文章 2009年学术文章 artikulong pang-agham article scientifique 2009年学术文章 vetenskaplig artikel 2009年學術文章 научна статия 2009年学术文章 სამეცნიერო სტატია teaduslik artikkel 2009年學術文章 2009년 논문 2009 nî lūn-bûn artikel ilmiah আগস্ট ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitenskapelig artikkel artículu científicu espublizáu en 2009 2009年学术文章 scienca artikolo наукова стаття, опублікована в серпні 2009 artigo científico scientific article published in August 2009 articol științific bài báo khoa học article científic 2009年の論文 scientific article published in August 2009 vedecký článok научная статья artigo científico научни чланак vitskapeleg artikkel article scientific 2009年學術文章 บทความทางวิทยาศาสตร์ мақолаи илмӣ artikull shkencor vědecký článek 2009年學術文章 مقالة علمية نشرت في أغسطس 2009 επιστημονικό άρθρο scientific article published in August 2009 artículo científico publicado en 2009 wetenschappelijk artikel artigo científico 2009年学术文章 naučni članak 2009年学术文章 научни чланак artykuł naukowy מאמר מדעי tieteellinen artikkeli
p:P577
wds:Q43292405-057B4F98-F5AB-44CA-AA41-65F270E13D70
wdt:P577
2009-08-01T00:00:00Z
p:P407
wds:Q43292405-9F63EDEB-08F2-4638-AE5B-A5833285DB8D
wdt:P407
wd:Q1860
p:P2093
wds:Q43292405-46052A5E-88A7-4142-91D7-B312B896B207 wds:Q43292405-204A9429-80FE-4807-96A2-CE910FF61810 wds:Q43292405-1EB82CA6-2402-488B-B003-05C2753DFBA1
wdt:P2093
Viliam Fridrich William F Penny Ariel Finkelstein
rdfs:label
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizi
skos:prefLabel
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizi
schema:name
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizi
p:P50
wds:Q43292405-2A099B2F-86A3-4282-A23D-F42C7CCA3914 wds:Q43292405-58A2D647-660E-49D0-B1E1-6BD63338B8DE wds:Q43292405-5D5A6DD6-0F9D-4AC6-92F2-6150773F542C wds:Q43292405-6E5C1F6B-2106-4D54-A4D0-30241423DD49 wds:Q43292405-F6D58342-2D34-48C9-A94E-54FACD6A71B4 wds:Q43292405-1156C741-5477-4D79-8FEA-E4BA2F24E82C wds:Q43292405-480E0F7B-CC48-4FF3-93E0-C4736F2DAD4D wds:Q43292405-167A6A11-C1B5-4787-B7E2-B53C3C93A130
wdt:P50
wd:Q96581274 wd:Q322114 wd:Q104737144 wd:Q89851175 wd:Q114427160 wd:Q64496972 wd:Q16027739 wd:Q114308442
p:P1476
wds:Q43292405-DBC91F20-07EA-4512-B1AF-184976098788
wdt:P1476
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizi
p:P304
wds:Q43292405-D8E43F3D-EC5C-4F44-8586-6B94FF6CAEBE
wdt:P304
678-685
p:P31
wds:Q43292405-2FC5557A-0C9A-44E3-90CA-6D200DDD896B
wdt:P31
wd:Q13442814
p:P921
wds:Q43292405-79542719-D845-4163-9764-2D07AA5AFC8D
wdt:P921
wd:Q266018
p:P698
wds:Q43292405-D31A79C9-78E7-47D8-A80E-3C657BE182EA
wdtn:P698
n12:19679245
wdt:P698
19679245
p:P1433
wds:Q43292405-B62C4ED0-857D-499F-89A8-0605675E89DF
wdt:P1433
wd:Q2984355
p:P433
wds:Q43292405-65260FA2-A67B-4406-8191-50E9C58B512E
p:P478
wds:Q43292405-CC9E4E9B-0A14-4E75-9911-AC6358765366
wdt:P433
8
wdt:P478
54
p:P356
wds:Q43292405-FC169860-72CC-454B-92EE-C743712EC25C
wdtn:P356
n6:J.JACC.2009.05.025
wdt:P356
10.1016/J.JACC.2009.05.025
p:P5875
wds:Q43292405-41DBBB82-3C46-40FD-A697-F13CB401DAFC
wdt:P5875
246669560